Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of hematopoietic stem cells that has been recognized as a disease responsive to immunotherapy. Despite the huge success of the tyrosine kinase inhibitors (TKIs), CML remains for the most part incurable, probably due to treatment resistance of leukemic stem cells, which are responsible for rapid disease relapse after discontinuation of therapy. Only allogeneic stem cell transplantation enables disease eradication. In addition to the Bcr-Abl1 oncoprotein, TKIs also inhibit off-target kinases (e.g. c-kit, Src, Tec), some of them having physiological functions in immune responses. In vitro studies have implied immunomodulatory effects of TKIs and interferon-alpha (IFN-α), but comprehensive information from in vivo analyses is missing. This review summarizes the recent advances in the field of immunology of CML, including basic information about leukemia-associated antigens and peptide vaccines, that could lead to the incorporation of TKIs and IFN-α in future therapeutic, potentially curative, interventions for CML.

University Hospital Olomouc Czech Republic

Zobrazit více v PubMed

Blood. 2004 Feb 1;103(3):1037-42 PubMed

N Engl J Med. 2010 Dec 23;363(26):2511-21 PubMed

Leukemia. 2009 Aug;23(8):1398-405 PubMed

Ann Intern Med. 1991 Apr 1;114(7):532-8 PubMed

Blood. 1994 Dec 15;84(12):4064-77 PubMed

Blood. 2007 Jan 15;109(2):500-2 PubMed

J Clin Oncol. 2010 Mar 10;28(8):1429-35 PubMed

Immunobiology. 2011 May;216(5):604-12 PubMed

Protein Cell. 2010 Feb;1(2):124-32 PubMed

PLoS One. 2011 Feb 03;6(2):e16700 PubMed

Int J Oncol. 2007 Nov;31(5):1133-9 PubMed

J Cell Mol Med. 2008 Oct;12(5B):2107-18 PubMed

Leukemia. 2008 Jun;22(6):1200-6 PubMed

Curr Drug Targets. 2011 Mar 1;12(3):420-8 PubMed

Curr Opin Immunol. 2009 Aug;21(4):440-5 PubMed

Leukemia. 2007 Nov;21(11):2287-95 PubMed

Int J Med Sci. 2010 Apr 20;7(2):72-81 PubMed

N Engl J Med. 2006 Dec 7;355(23):2408-17 PubMed

Lancet. 2005 Feb 19-25;365(9460):657-62 PubMed

Eur J Haematol. 2008 Jun;80(6):461-8 PubMed

Expert Rev Mol Med. 2007 May 24;9(14):1-17 PubMed

Leukemia. 2011 Oct;25(10):1587-97 PubMed

Clin Immunol. 2008 Jun;127(3):330-9 PubMed

Blood. 2007 Dec 1;110(12):4055-63 PubMed

Leuk Lymphoma. 2005 May;46(5):717-22 PubMed

Cancer. 2010 Jun 1;116(11):2665-72 PubMed

Immunol Rev. 2004 Dec;202:8-32 PubMed

Nature. 2009 Apr 16;458(7240):904-8 PubMed

Blood. 1992 Apr 15;79(8):1920-3 PubMed

Apoptosis. 2003 Jun;8(3):237-49 PubMed

Trends Mol Med. 2009 Jun;15(6):275-84 PubMed

Folia Biol (Praha). 2006;52(3):47-58 PubMed

Eur J Clin Invest. 2009 Dec;39(12):1098-109 PubMed

Cancer. 2009 Sep 1;115(17):3924-34 PubMed

Int J Hematol. 2010 Jun;91(5):799-807 PubMed

Blood. 2009 Jan 22;113(4):875-82 PubMed

Expert Rev Hematol. 2009 Feb;2(1):81-91 PubMed

Cell. 2008 May 30;133(5):775-87 PubMed

Cancer Control. 2009 Apr;16(2):141-52 PubMed

J Clin Invest. 2003 Mar;111(5):639-47 PubMed

Eur J Haematol. 2010 Nov;85(5):387-98 PubMed

Blood. 2008 Feb 1;111(3):1357-65 PubMed

Leukemia. 2007 Nov;21(11):2363-8 PubMed

Blood. 2008 Feb 1;111(3):1366-77 PubMed

Blood. 2001 Nov 15;98(10):3074-81 PubMed

Leukemia. 2009 Jan;23(1):53-8 PubMed

Leuk Lymphoma. 2012 Jun;53(6):1084-9 PubMed

Trends Immunol. 2001 Nov;22(11):633-40 PubMed

Oncologist. 2001;6(1):34-55 PubMed

Blood. 2000 Nov 15;96(10):3343-56 PubMed

Blood. 2008 Apr 15;111(8):4415-6 PubMed

Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):459-71 PubMed

Leuk Res. 1998 Feb;22(2):175-84 PubMed

PLoS One. 2010 Jul 26;5(7):e11770 PubMed

Leukemia. 1997 Jul;11(7):933-9 PubMed

Blood. 2003 Oct 15;102(8):2892-900 PubMed

J Clin Oncol. 2002 Jan 1;20(1):214-20 PubMed

Blood. 2010 Aug 5;116(5):673-4 PubMed

Haematologica. 2010 Aug;95(8):1415-9 PubMed

Blood. 2008 Sep 1;112(5):1876-85 PubMed

J Interferon Cytokine Res. 2011 Jul;31(7):553-9 PubMed

Clin Cancer Res. 2008 Apr 15;14(8):2484-91 PubMed

N Engl J Med. 2010 Jun 17;362(24):2251-9 PubMed

Blood. 2009 Mar 5;113(10):2238-44 PubMed

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4547-55 PubMed

Blood. 2003 Jan 1;101(1):259-64 PubMed

Blood. 2010 Aug 5;116(5):772-82 PubMed

Blood. 2007 Nov 15;110(10):3540-6 PubMed

Leuk Res. 2011 Jan;35(1):80-6 PubMed

Haematologica. 2005 Oct;90(10):1324-32 PubMed

Blood. 2008 Jan 1;111(1):236-42 PubMed

Haematologica. 2009 Jan;94(1):135-9 PubMed

Best Pract Res Clin Haematol. 2008 Sep;21(3):437-53 PubMed

Exp Hematol. 2007 Aug;35(8):1266-71 PubMed

Cytokines Cell Mol Ther. 2002;7(4):143-9 PubMed

Leuk Lymphoma. 2011 Apr;52(4):668-79 PubMed

Leukemia. 2007 Oct;21(10):2145-52 PubMed

Int J Cancer. 2010 Nov 1;127(9):2119-28 PubMed

PLoS One. 2011;6(8):e23022 PubMed

Blood. 2007 Jan 1;109(1):58-60 PubMed